Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, November 30 2009 10:50pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
View: Latest News | Top Stories
Friday, Nov 6, 2009
·Novavax 3Q loss narrows on cost cuts
AP - Fri Nov 6
·[external] Inhibitex records $4.5 million loss
at bizjournals.com - Fri Nov 6
·[external] Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
at TheStreet.com - Fri Nov 6
·Threshold Pharmaceuticals 3Q loss widens on costs
AP - Fri Nov 6
·[external] Biotech Stocks: Drug stocks mixed; Alkermes slides
at MarketWatch - Fri Nov 6
·Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors
Wall Street Transcript - Fri Nov 6
·[external] GeoVax shows Q3 improvement
at bizjournals.com - Fri Nov 6
·[external] Targacept reports $1.3M profit
at bizjournals.com - Fri Nov 6
·Jazz Pharma 3Q loss narrows on Xyrem sales
AP - Fri Nov 6
·CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
PR Newswire - Fri Nov 6
·GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
PR Newswire - Fri Nov 6
·Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting
GlobeNewswire - Fri Nov 6
·Targacept reports 3Q profit on boost in payments
AP - Fri Nov 6
·Ariad's 3Q loss widens slightly on costs
AP - Fri Nov 6
·Novavax Reports Third Quarter 2009 Financial Results
PR Newswire - Fri Nov 6
·XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases
GlobeNewswire - Fri Nov 6
·GTC Biotherapeutics Reports Third Quarter 2009 Financial Results
Business Wire - Fri Nov 6
·Cytokinetics Announces Addition to Board of Directors
Marketwire - Fri Nov 6
·Halozyme Therapeutics Reports Third Quarter 2009 Financial Results
Business Wire - Fri Nov 6
·RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
Business Wire - Fri Nov 6
More Latest News...
Sponsor Results
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT.
www.GFTforex.com
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
www.sharebuilder.com
Top Biotechnology Stocks
3 Pharmaceutical Companies To Invest In Now! Get The Free Report.
www.Fool.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.
Questions or Comments?